Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

23.99
Delayed Data
As of 4:02pm ET
 -0.02 / -0.08%
Today’s Change
10.85
Today|||52-Week Range
33.82
+26.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$20.7B

Company Description

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva Hamerkaz 49131
P:(723) 926-7267
Investor Relations:
(215) 591-8912

Employees

Shareholders

Mutual fund holders35.40%
Other institutional31.00%
Individual stakeholders0.15%

Top Executives

Kåre SchultzPresident, Chief Executive Officer & Director
Carlo de NotaristefaniExecutive Vice President-Global Operations
Michael McClellanChief Financial Officer & Executive Vice President
David StarkChief Legal Officer & Executive Vice President
Nir BaronChief Internal Auditor & Executive Vice President